Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Assessment of motor function and nutritional status in children with spinal muscular atrophy treated with nusinersen after loading period in Western China: a retrospective study

Fig. 1

Disease duration as a predictor of gain in HFMSE after 2 months of treatment. A change of two or more points in HFMSE showed in the figure. In the group that experienced motor responses the median disease duration was 0.23 ± 0.05 years, compared to the median disease duration of 0.47 ± 0.08 years in the group of patients that remained stable or worsened (P = 0.013)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us